Bayer AG

Equities

BAYN

DE000BAY0017

Market Closed - Xetra Other stock markets 03:35:55 17/01/26 am AEDT			5-day change	1st Jan Change
41.52 ^EUR	-1.38%		+6.78%	+12.17%

17/01	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
17/01	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE

Transcript : Bayer Aktiengesellschaft, Q3 2025 Earnings Call, Nov 12, 2025

Published on 11/13/2025 at 02:20 am AEDT - Modified on 11/13/2025 at 09:23 am AEDT

S&P Capital IQ

Presenter Speech
Jost Reinhard (Executives)

Good afternoon and good morning, everybody, and welcome to our conference call to discuss the results for the third quarter of 2025. For our presentation

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bayer AG

17/01	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
17/01	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE
17/01	Bayer AG - Company expects a decision on merits during court's 2026 session, which ends in June	RE
17/01	Bayer AG - U.S. Supreme Court today announced that it will review Durnell Roundup case	RE
17/01	US Supreme Court to hear Bayer's bid to curb Roundup cases	RE
17/01	U.S. Supreme Court agrees to hear Bayer's bid to limit lawsuits filed under state laws over its weedkiller Roundup	RE
17/01	Bayer's Eylea Secures EU Approval for Retinal Vein Occlusion	MT
16/01	MWB Research Upgrades Bayer to Buy, Boosts PT	MT
16/01	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
16/01	Bayer says Eylea 8 mg approved in the EU for third retinal indication	RE
16/01	BAYER AG : UBS sticks Neutral	ZD
16/01	Dax Expected to Open Lower – Inflation and Auto Sector in Focus	RE
16/01	Bayer Upgraded to Buy as mwb Notes 'Improving Medium-term Risk-Reward'	MT
15/01	European Midday Briefing : Shares Rise; Gold and Oil Fall on Easing U.S.-Iran Tensions	DJ
15/01	German DAX Index Slips; Bayer, RWE Shares Surge	MT
15/01	Frankfurt Stocks Close: DAX Ends Impressive Record-Breaking Streak	DP
15/01	Orion Sees Long-Term Nubeqa Sales Surpassing 1 Billion Euros – Issues 2026 Forecast (Update)	FW
15/01	Orion Estimates to Hit Annual Net Sales Target for Nubeqa by Decade-end	MT
15/01	Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug	DJ
14/01	Bayer Continues Recovery Rally – Sees Major Pharma Potential Ahead	DP
14/01	Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle
14/01	Bayer Sees Pharmaceutical Business on Growth Trajectory	DP
14/01	U.S. Futures Fall, Precious Metals Gain on Iranian Unrest	DJ
14/01	Historic Morning Record for the CAC 40
14/01	Bayer Targets Around 30 Percent Margin for Pharma Division by 2030	RE